Nanjing Shenji Pharmaceutical Technology Co., Ltd.

Nanjing Shenji Pharmaceutical is a high-tech enterprise focusing on the research and development of IVD raw materials and downstream technologies. R&D personnel account for 60% of the company's total employees, and more than 40% of employees have master's degrees. They have obtained more than 60 patents and more than ten invention patents. The company's production workshop exceeds 10,000 square meters, achieving full chain coverage from technology platform, raw material synthesis to end products. The high-end hardware facilities include a 5,000-square-meter GMP production workshop for in vitro diagnostics and a 6,000-square-meter clean packaging production workshop, with fully automatic production lines and a daily production capacity of 3 million test kits. Intelligent software is used to monitor the production status of fully automatic equipment in real time on computers and mobile phones to ensure stable, efficient and high-quality production of equipment. Innovative and Robust R&D Strength The company has a mature IVD raw material R&D platform, such as protein expression and purification platform, hybridoma monoclonal antibody screening platform, antibody engineering design and expression platform, etc.; providing a solid technical foundation for the development of diagnostic antibodies. Rich antibody verification process platforms, including colloidal gold platform, fluorescence chromatography platform, latex turbidity platform, and chemiluminescence platform, the performance of raw materials has been fully verified. Our products cover infectious diseases, drug testing, cardiovascular diseases, gastrointestinal diseases, pregnancy testing, pet disease diagnosis and other fields. Many products have obtained EU CE certification, the Ministry of Commerce's export whitelist, and access qualifications from multiple countries and regions. The products sell well in many overseas countries and contribute to the "great health" of all mankind.